Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1.04B |
| 2 |
Palo Alto Networks
PANW
|
+$957M |
| 3 |
Medtronic
MDT
|
+$433M |
| 4 |
Pinterest
PINS
|
+$422M |
| 5 |
Colgate-Palmolive
CL
|
+$396M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.38B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$967M |
| 3 |
Apple
AAPL
|
+$847M |
| 4 |
Meta Platforms (Facebook)
META
|
+$700M |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$576M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.9% |
| 2 | Financials | 7.33% |
| 3 | Healthcare | 6.04% |
| 4 | Consumer Discretionary | 5.46% |
| 5 | Communication Services | 3.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4076
iShares MSCI Poland ETF
EPOL
$756M
| $29K | ﹤0.01% |
1,985
| – | – |
|
4077
Franklin Covey
FC
$246M
| $29K | ﹤0.01% |
632
-1,415
| -69% | -$56.3K |
|
4078
Immunocore
IMCR
$1.73B
| $29K | ﹤0.01% |
776
-332
| -30% | -$10.8K |
|
4079
KRONOS Worldwide
KRO
$989M
| $29K | ﹤0.01% |
1,613
-2,610
| -62% | -$44.6K |
|
|
LITS
4080
Lite Strategy Inc
LITS
$30.9M
| $29K | ﹤0.01% |
2,432
-1,063
| -30% | -$11.6K |
|
4081
York Water
YORW
$514M
| $29K | ﹤0.01% |
713
-1,462
| -67% | -$59.2K |
|
|
THRX
4082
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
| $29K | ﹤0.01% |
5,192
-1,018
| -16% | -$8.41K |
|
|
CCF
4083
DELISTED
Chase Corporation
CCF
| $29K | ﹤0.01% |
379
-864
| -70% | -$70.8K |
|
4084
AvePoint
AVPT
$2.71B
| $28K | ﹤0.01% |
6,465
+6,088
| +1,615% | +$30.9K |
|
4085
Barclays
BCS
$94.1B
| $28K | ﹤0.01% |
3,665
| – | – |
|
4086
BeyondSpring
BYSI
$35.8M
| $28K | ﹤0.01% |
18,991
-2,560
| -12% | -$4.27K |
|
4087
Geron
GERN
$949M
| $28K | ﹤0.01% |
18,032
-32,559
| -64% | -$46K |
|
4088
ESS Tech
GWH
$18.9M
| $28K | ﹤0.01% |
671
-1,252
| -65% | -$87.8K |
|
4089
Hims & Hers Health
HIMS
$7.31B
| $28K | ﹤0.01% |
6,092
+5,731
| +1,588% | +$24.4K |
|
4090
i3 Verticals
IIIV
$342M
| $28K | ﹤0.01% |
1,105
-2,475
| -69% | -$62.4K |
|
4091
JPMorgan Equity Premium Income ETF
JEPI
$45.9B
| $28K | ﹤0.01% |
+500
| New | +$28.9K |
|
4092
Minerva Neurosciences
NERV
$199M
| $28K | ﹤0.01% |
+8,430
| New | +$34.4K |
|
4093
Winmark
WINA
$1.32B
| $28K | ﹤0.01% |
143
-434
| -75% | -$88.9K |
|
|
PWSC
4094
DELISTED
PowerSchool Holdings, Inc.
PWSC
| $28K | ﹤0.01% |
2,288
-4,879
| -68% | -$67K |
|
|
EGIO
4095
DELISTED
Edgio, Inc. Common Stock
EGIO
| $28K | ﹤0.01% |
302
-476
| -61% | -$68.5K |
|
|
MORF
4096
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $28K | ﹤0.01% |
1,291
-2,323
| -64% | -$64.9K |
|
|
AGTI
4097
DELISTED
Agiliti Inc
AGTI
| $28K | ﹤0.01% |
1,377
-2,590
| -65% | -$51.7K |
|
|
SIEN
4098
DELISTED
Sientra, Inc.
SIEN
| $28K | ﹤0.01% |
3,379
-942
| -22% | -$12.8K |
|
|
HARP
4099
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $28K | ﹤0.01% |
1,443
-304
| -17% | -$7.87K |
|
|
CTIC
4100
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $28K | ﹤0.01% |
4,664
+4,648
| +29,050% | +$23.8K |
|
Similar funds
Barclays's Q2 2022 Portfolio in Review
As of Q2 2022, Barclays held 5,544 positions worth $163B, up 28% from $128B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Barclays deployed $63.1B of net new capital in Q2 2022, opening 560 new positions and adding to 1,332 existing holdings. Its largest new stake was Fisker Inc.: 3,607,227 shares worth $30.9M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.38B trimmed.
- Barclays's largest Q2 2022 buy was Fisker Inc.: 3,607,227 shares worth $30.9M.
- Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q2 2022, an estimated $1.04B increase.
- Barclays's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.38B.
- Barclays fully exited Cerner Corp in Q2 2022, selling an estimated $432M.
- Barclays's ten largest holdings make up 39% of its $163B portfolio in Q2 2022.
- Barclays opened 560 new positions and closed 413 in Q2 2022.
- Barclays's portfolio value rose 28% quarter-over-quarter to $163B.
Based on Barclays's 13F filing for Q2 2022, filed 12 Aug 2022.